Reduced Intimal Thickening Following αvβ 3 Blockade is Associated with Smooth Muscle Cell Apoptosis

Cell Communication and Adhesion

Volumn 6, Issue 5, 1998, Pages 371-379

  Zee, Rien Vander ^a,c   Murohara, Toyoaki ^a   Passeri, Jonathan ^a   Kearney, Marianne ^a   Cheresh, David A ^b   Isner, Jeffrey M ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Angioplasty; apoptosis; endothelial cells; integrin receptors; Restenosis; smooth muscle cells

Indexed keywords

INTEGRIN; INTEGRIN RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY LM 609; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; ILIAC ARTERY; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RABBIT; RECEPTOR BLOCKING; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; BALLOON DILATATION; ENDOTHELIUM; MUSCLE, SMOOTH; RABBITS; RECEPTORS, VITRONECTIN; TIME FACTORS; TUNICA INTIMA;

EID: 0032436238     PISSN: 15419061     EISSN: 15435180     Source Type: Journal    
DOI: 10.3109/15419069809109146     Document Type: Article

References (25)

1. Asahara T., Bauters C., Pastore C J., Kearney M., Rossow S., Bunting S., Ferrara N., Symes J. F., Isner J. M. Local delivery of vascular endothelial growth factor accelerates re-endothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 1995; 91: 2793 – 2801
2. Asahara T., Chen D., Tsurumi Y., Kearney M., Rossow S., Passed J., Symes J., Isner J. Accelerated restitution of endothelial integrity and endothelium dependent function following phVEGF16s gene transfer. Circulation 1996; 94: 3291 – 3302
3. Bjornsson T. D., Dryjski M., Tluczek J., Mennie R., Ronan J., Mellin T. N., Thomas K. A. Acidic fibroblast growth factor promotes vascular repair. Proceedings of the National Academy of Science (USA) 1991; 88: 8651 – 8655
4. Bochaton-Piallat M. L., Gabbiani F, Redard M., Desmouliere A., Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. American Journal of Pathologv 1995; 146: 1059 – 1064
5. Breier G., Albrecht U., Sterrer S., Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 1992; 114: 521 – 532
6. Brooks P. C., Clark R. A.F., Cheresh D. A. Requirement of vascular integrin alpha-v-beta-3 for angiogenesis. Science 1994a; 264: 569 – 571
7. Brooks P. C., Montgomery A. M.P., Rossenfeld M., Reisfeld R. A., Hu T., Killer G., Cheresh D. A. Integrin alpha-v-beta-3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994b; 79: 1157 – 1164
8. Clark R. A.F., Tonnesen M. G., Gailit J., Cheresh D. A. Transient functional expression of alpha-v-beta-3 on vascular cells during wound repair. American Journal of Pathology 1996; 148: 1407 – 1421
9. Clowes A. W., Reidy M. A., Clowes M. M. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Laboratory Investigation 1983; 49: 327 – 333
10. Coller B. S., Peerschke E. I., Scudder L. E., Sullivan C. A. A murine monoclonal antibody that completely blocks the binding of the fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins lib and/or Ilia. Journal of Clinical Investigation 1983; 72: 325 – 328
11. Epstein S. E., Siegall C. B., Biro S., Fu Y. M., FitzGerald D., Pastan I. Cytotoxic effects of a recombinant chimeric toxin on rapidly proliferating vascular smooth muscle cells. Circulation 1991; 84: 778 – 787
12. Feldman L. J., Steg P. G., Zheng L. P., Chen D., Kearney M., McGarr S. E., Barry J. D., Dedieu J. P., Perricaudet M., Isner J. M. Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit. Journal of Clinical Investigation 1995; 95: 2662 – 2671
13. Hoshiga M., Alpers C. E., Smith L. L., Giachelli C M., Schwartz S. M. Alpha-v-beta-3 integrin expression in normal and atherosclerotic artery. Circulation Research 1995; 11: 1129 – 1135
14. Isner J. M., Kearney M., Bortman S., Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation 1995; 91: 2703 – 2711
15. Lefkovits J., Plow E. F., Topol E. J. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. New England Journal of Medicine 1995; 332: 1553 – 1559
16. Lindner V., Majack R. A., Reidy M. A. Basic fibroblast growth factor stimultaes endothelial regrowth and proliferation in denuded arteries. Journal of Clinical Investigation 1990; 85: 2004 – 2008
17. Miano J. M., Vlasic N., Tota R. R., Stemerman M. B. Smooth muscle cell immediate-early gene and growth factor activation follows vascular injury: a putative in vivo mechanism for autocrine growth. Arteriosclerosis and Thrombosis 1993; 13: 211 – 219
18. Okada Y., Copeland B. R., Hamann G. F., Koziol J. A., Cheresh D. A., del Zoppo G. J. Integrin alpha-v-beta-3 is expressed in selected microvessels after focal cerebral ischemia. American Journal of Pathology 1996; 149: 37 – 44
19. Riessen R., Isner J. M. Prospects for site-specific delivery of pharmacologic and molecular therapies. Journal of the American College of Cardiology 1994; 23: 1234 – 1244
20. Ruoslahti E., Reed J. C. Anchorage dependence, integrins, and apoptosis. Cell 1994; 11: 477 – 478
21. Schwartz S. M., Haudenschild C. C., Eddy E. M. Endothelial regeneration. I. Quantitative analysis of initial stages of endothelial regeneration in rat aortic intima. Laboratory Investigation 1978; 568 – 580
22. Skinner M. P., Raines E. W., Ross R. Dynamic expression of alpha-1-beta-1 and alpha-2-beta-l integrin receptors by human vascular smooth muscle cells: alphas-beta-1 integrin is required for chemotaxis across type I collagen-coated membranes. American Journal of Pathology 1994; 145: 1070 – 1081
23. Stromblad S., Becker J. C, Yebra M., Brooks P C, Cheresh D. A. Suppression of p53 activity and p2]WAFi cipi expression by vascular cell integrin alpha-v-beta-3 during angiogenesis. Journal of Clinical Investigation 1996; 98: 426 – 433
24. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. New England Journal of Medicine 1994; 330: 956 – 961
25. Topol E. J., Califf R. M., Weisman H. F. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet 1994; 343: 881 – 886